Pfizer Inc BDR (PFIZ34)

69.42 +1.06 (+1.55%)
Closed BRL Disclaimer

PFIZ34 Financial Summary

For the three months ended 03 April 2022, Pfizer Inc. revenues increased 77% to $25.66B. Net income applicable to common stockholders excluding extraordinary items increased 61% to $7.87B. Revenues reflect Vaccines-Comimaty direct sales and alliance revenues segment increase from $3.46B to $13.23B, Hospital-Paxlovid segment increase from $0K to $1.47B, Developed Europe segment increase from $2.82B to $7.37B.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
PFIZ34
Gross margin TTM 60.45%
Operating margin TTM 30.32%
Net Profit margin TTM 27.56%
Return on Investment TTM 18.43%
Total Revenue
Net Income
Title
Apr 03, 2022
Dec 31, 2021
Oct 03, 2021
Jul 04, 2021
Total Revenue 25,661 23,635 24,094 18,977
Gross Profit 15,651 14,024 14,169 11,991
Operating Income 9,873 4,576 7,647 5,914
Net Income 7,863 3,393 8,146 5,564
Clear All
0Selected
Please try another search
PFIZ34
Quick Ratio MRQ 1.13
Current Ratio MRQ 1.39
LT Debt to Equity MRQ 43.26%
Total Debt to Equity MRQ 44.04%
Total Assets
Total Liabilities
Title
Apr 03, 2022
Dec 31, 2021
Oct 03, 2021
Jul 04, 2021
Total Assets 183,841 181,476 179,188 169,920
Total Liabilities 101,417 104,276 103,496 99,878
Total Equity 82,424 77,200 75,692 70,042
Clear All
0Selected
Please try another search
PFIZ34
Cash Flow/Share TTM 5.34
Revenue/Share TTM 16.11
Operating Cash Flow 16.66%
Cash
Net Change in Cash
Title
Apr 03, 2022
Dec 31, 2021
Oct 03, 2021
Jul 04, 2021
Cash From Operating Activities 6,541 32,580 26,666 15,836
Cash From Investing Activities 567 -22,546 -19,960 -9,884
Cash From Financing Activities -6,578 -9,816 -6,465 -5,364
Net Change in Cash 529 159 209 593
Clear All
0Selected
Please try another search

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.